Abstract：
Clinical laboratories perform a variety of tests for which biomedical waste is a byproduct. Of these, the complete metabolic panel (CMP) produces a significant portion of this waste. We investigated specific waste subsequent to performing CMPs over the course of a year and analyzed what percentage of the waste produced could have been recycled.
Patient testing volumes were collected retrospectively from July 14, 2021, to July 14, 2022, for individual assays within the CMP performed on Abbott Alinity c instruments (n = 6). The average weights for components of the reagent kits, which includes wedges, boxes, and package inserts, were calculated. These weights, in conjunction with total patient testing volumes, were used to determine the amount of waste produced.
A total of 1089.2 kg of reagent kit waste was estimated to be produced by performing CMPs throughout a year. Of this waste, most (855.5 kg) was not recyclable, but a subset (233.6 kg) was. Overall, 21.4% of the total specific waste weight was found to be recyclable.
The CMP contributes a substantial amount of waste when performed on chemistry analyzer platforms in the clinical laboratory. Paper inserts and cardboard packaging, however, presented opportunities for recycling.
Patient testing volumes were collected retrospectively from July 14, 2021, to July 14, 2022, for individual assays within the CMP performed on Abbott Alinity c instruments (n = 6). The average weights for components of the reagent kits, which includes wedges, boxes, and package inserts, were calculated. These weights, in conjunction with total patient testing volumes, were used to determine the amount of waste produced.
A total of 1089.2 kg of reagent kit waste was estimated to be produced by performing CMPs throughout a year. Of this waste, most (855.5 kg) was not recyclable, but a subset (233.6 kg) was. Overall, 21.4% of the total specific waste weight was found to be recyclable.
The CMP contributes a substantial amount of waste when performed on chemistry analyzer platforms in the clinical laboratory. Paper inserts and cardboard packaging, however, presented opportunities for recycling.
摘要：
目的：临床实验室进行各种测试，生物医学废物是副产品。其中,完整的代谢小组（CMP）产生了这种废物的很大一部分。我们调查了一年内执行CMP后的特定废物，并分析了可以回收的废物百分比。
方法：回顾性收集2021年7月14日至2022年7月14日的患者检测量，用于在AbbottAlinityc仪器上进行CMP内的单独检测（n=6）。试剂盒成分的平均重量，其中包括楔子，boxes,和包装插页，被计算。这些重量，结合患者总测试量，用于确定产生的废物量。
结果：估计全年进行CMP会产生总计1089.2kg的试剂盒废物。在这种浪费中，大多数(855.5公斤)是不可回收的，但一个子集（233.6公斤）。总的来说,发现总特定废物重量的21.4％是可回收的。
结论：当在临床实验室的化学分析仪平台上进行时，CMP会产生大量的废物。纸插入物和纸板包装，然而,提供了回收的机会。
方法：回顾性收集2021年7月14日至2022年7月14日的患者检测量，用于在AbbottAlinityc仪器上进行CMP内的单独检测（n=6）。试剂盒成分的平均重量，其中包括楔子，boxes,和包装插页，被计算。这些重量，结合患者总测试量，用于确定产生的废物量。
结果：估计全年进行CMP会产生总计1089.2kg的试剂盒废物。在这种浪费中，大多数(855.5公斤)是不可回收的，但一个子集（233.6公斤）。总的来说,发现总特定废物重量的21.4％是可回收的。
结论：当在临床实验室的化学分析仪平台上进行时，CMP会产生大量的废物。纸插入物和纸板包装，然而,提供了回收的机会。
